The state-of-the-art Targeted Therapy services offered by Fortis Memorial Research Institute, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Gurgaon, India. Founded in 2013, the JCI, NABH, NABL accredited hospital has 311 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.